Retrobulbar Methylprednisolone as Adjunctive Treatment in Optic Neuritis Trial
Status:
Recruiting
Trial end date:
2023-09-15
Target enrollment:
Participant gender:
Summary
A double-blind prospective randomized clinical trial of treatment for optic neuritis
comparing visual outcome of patients treated by standard therapy (intravenous
methylprednisolone) + placebo injection and standard therapy + retrobulbar
methylprednisolone.